logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa

Harries AD, Zachariah R, Lawn SD, Rosen S
2010-06-01 • Tropical Medicine and International Health
2010-06-01 • Tropical Medicine and International Health
The scale-up of antiretroviral therapy (ART) has been one of the success stories of sub-Saharan Africa, where coverage has increased from about 2% in 2003 to more than 40% 5 years later....
Journal Article
|
Commentary

Emerging priorities for HIV service delivery

Ford NP, Geng EH, Ellman T, Orrell C, Ehrenkranz PD,  et al.
2020-02-14 • PLOS Medicine
2020-02-14 • PLOS Medicine
Journal Article
|
Commentary

Tailored HIV programmes and universal health coverage

Holmes CB, Rabkin M, Ford NP, Preko P, Rosen S,  et al.
2019-09-27 • Bulletin of the World Health Organization
2019-09-27 • Bulletin of the World Health Organization
Improvements in geospatial health data and tailored human immunodeficiency virus (HIV) testing, prevention and treatment have led to greater microtargeting of the HIV response, based on ...
Journal Article
|
Research

Early Outcomes of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study

Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D,  et al.
2016-11-03 • PLOS One
2016-11-03 • PLOS One
OBJECTIVE: We describe baseline characteristics, time to treatment initiation and interim patient outcomes at a decentralized, outpatient treatment site for rifampicin-resistant TB (RR-T...